These results demonstrate that apelin levels might have a significant clinical use as a marker/predictor of cardiovascular mortality and need for hospitalization, and a therapeutic role for CKD patients with cardiovascular disease is plausible. The gene discussed is APLN; the disease is chronic kidney disease.